tyramine has been researched along with paclitaxel in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dráber, P; Dráberová, E; Hájková, Z; Stegurová, L; Sulimenko, V | 1 |
| Chen, Z; Clinton, SK; Huang, J; Jin, VX; Lan, X; Liu, Z; Sunkel, B; Wang, Q; Wu, D; Ye, Z | 1 |
| Chantharasamee, J; Ithimakin, S; Singsuksawat, E; Sootichote, R; Thuwajit, C; Thuwajit, P; Warnnissorn, M; Yenchitsomanus, PT | 1 |
1 review(s) available for tyramine and paclitaxel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for tyramine and paclitaxel
| Article | Year |
|---|---|
Quantification of α-tubulin isotypes by sandwich ELISA with signal amplification through biotinyl-tyramide or immuno-PCR.
Topics: Animals; Antibodies, Monoclonal; Biotin; Cell Line; Enzyme-Linked Immunosorbent Assay; Epitope Mapping; Mast Cells; Mice; Paclitaxel; Polymerase Chain Reaction; Protein Isoforms; Thapsigargin; Tubulin; Tyramine | 2013 |
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer.
Topics: Acetates; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Dexamethasone; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Ligands; Paclitaxel; Receptors, Glucocorticoid; Response Elements; Reverse Transcriptase Polymerase Chain Reaction; Triple Negative Breast Neoplasms; Tyramine | 2015 |
Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8.
Topics: Acetates; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Interleukin-6; Interleukin-8; Melanoma; Paclitaxel; Signal Transduction; Toll-Like Receptor 4; Tumor Microenvironment; Tyramine | 2018 |